KRAS and fibrolamellar hepatocellular carcinoma: In colorectal and pancreatic cancer, there is one study utilizing a pooled mutant-KRAS peptide vaccine (NCT04117087), and in fibrolamellar hepatocellular carcinoma (FLC), a DNAJB1-PRKACA fusion kinase peptide vaccine (NCT04248569).